Cancer treatment and survivorship statistics, 2019
Cancer treatment and survivorship statistics, 2019
复制标题
DOI：
10.3322/caac.21565
复制
发表时间：
2019-09-01
影响因子：
254.7
通讯作者：
Siegel, Rebecca L.
中科院分区：
文献类型：
--
作者：
Miller, Kimberly D.;Nogueira, Leticia;Siegel, Rebecca L.
由于人口的增长和老龄化以及早期发现和治疗的进步，美国癌症幸存者的数量继续增加。为了帮助公共卫生界更好地为这些人提供服务，美国癌症协会和国家癌症研究所每3年合作一次，利用来自监测、流行病学和最终结果癌症登记处的发病率和生存率数据估计美国的癌症患病率;来自疾病控制和预防中心国家健康统计中心的生命统计数据;和美国人口普查局的人口预测。目前的治疗模式的基础上，在国家癌症数据库的信息是最流行的癌症类型。癌症相关和治疗相关的短期，长期和后期的健康影响也进行了简要描述。2019年1月1日，超过1690万有癌症史的美国人（810万男性和880万女性）还活着;仅根据人口的增长和老龄化，到2030年1月1日，这一数字预计将达到2210万以上。2019年最常见的三种癌症是男性的前列腺（3，650，030），结肠和直肠（776，120）和皮肤黑色素瘤（684，470），女性的乳腺癌（3，861，520），子宫体（807，860）和结肠和直肠（768，650）。超过一半（56%）的幸存者是在过去10年内确诊的，近三分之二（64%）的人年龄在65岁或以上。有癌症病史的人有独特的医疗和心理需求，需要后续护理提供者进行积极的评估和管理。虽然有越来越多的工具可以帮助患者，护理人员和临床医生在癌症生存的各个阶段进行导航，但需要进一步的循证资源来优化护理。
The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau. Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types. Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described. More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone. The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females. More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers. Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.